Gene Editing (BK2569) Stock Forum and Discussion

Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

1488.803
+0.406+0.03%

Close Oct 15 16:00 ET

1498.909High1483.872Low

Constituent Stocks: 10Top Rising: SGMO+4.75%

EZ_money

Yesterday 06:17

$Apellis Pharmaceuticals (APLS.US)$ should be 40 😁

EZ_money

Yesterday 02:35

$Apellis Pharmaceuticals (APLS.US)$

BigAlMoney

Yesterday 01:27

Fabry Deal coming?

$Sangamo Therapeutics (SGMO.US)$
Hope so. Big position here under $0.60
GLTA.

EZ_money

Oct 14 09:18

$Apellis Pharmaceuticals (APLS.US)$ 40 😁

Yolion

Oct 11 07:55

Share Your Profit/Loss

Strik57

Oct 10 16:14

$bluebird bio (BLUE.US)$ It's a high risk stock in my opinion worth the risk have some in your portfolio if your diversed already.just saying health care stock worth investing percentage in,good luck

The real Honey bee

Oct 9 16:28

$Sangamo Therapeutics (SGMO.US)$ RIP

105482297

Oct 8 08:20

$bluebird bio (BLUE.US)$ useless stock. sold off already

Sangamo seeks court validation for stock amendmentInvesting.comEditorLina GuerreroPublished 10/04/2024, 05:00 PM

$Sangamo Therapeutics (SGMO.US)$
This legal step underscores Sangamo's efforts to ensure its corporate actions comply with legal standards and underscores the company's commitment to its stockholders' interests. The outcome of the hearing will determine the definitive status of the common stock increase amendment. This information is based on a press release statement
Sangamo seeks court validation for stock amendment By Investing.com

No comment yet